BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19458350)

  • 1. Some things just have to be done in vivo: GPIHBP1, caloric delivery, and the generation of remnant lipoproteins.
    Williams KJ
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):792-5. PubMed ID: 19458350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
    Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
    Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
    Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650).
    Wang J; Hegele RA
    Lipids Health Dis; 2007 Sep; 6():23. PubMed ID: 17883852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
    Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
    J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPIHBP1: two get tangled.
    Vallerie SN; Bornfeldt KE
    Circ Res; 2015 Feb; 116(4):560-2. PubMed ID: 25677513
    [No Abstract]   [Full Text] [Related]  

  • 7. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.
    Young SG; Fong LG; Beigneux AP; Allan CM; He C; Jiang H; Nakajima K; Meiyappan M; Birrane G; Ploug M
    Cell Metab; 2019 Jul; 30(1):51-65. PubMed ID: 31269429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
    Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
    N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
    Chiu AP; Wan A; Lal N; Zhang D; Wang F; Vlodavsky I; Hussein B; Rodrigues B
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):145-55. PubMed ID: 26586663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.
    Adeyo O; Goulbourne CN; Bensadoun A; Beigneux AP; Fong LG; Young SG
    J Intern Med; 2012 Dec; 272(6):528-40. PubMed ID: 23020258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
    Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
    J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
    Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
    Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPIHBP1 and Plasma Triglyceride Metabolism.
    Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
    Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
    Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
    Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.
    Birrane G; Beigneux AP; Dwyer B; Strack-Logue B; Kristensen KK; Francone OL; Fong LG; Mertens HDT; Pan CQ; Ploug M; Young SG; Meiyappan M
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1723-1732. PubMed ID: 30559189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance.
    Surendran RP; Udayyapan SD; Clemente-Postigo M; Havik SR; Schimmel AWM; Tinahones F; Nieuwdorp M; Dallinga-Thie GM
    PLoS One; 2018; 13(11):e0205858. PubMed ID: 30408040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.